Difference between revisions of "Advanced Tissue Sciences"
(Created page with "right|thumb| Advanced Tissue Sciences is a corporation based in La Jolla, CA. They are the makers of Dermagraft-TC, which is an arti...") |
m |
||
| Line 1: | Line 1: | ||
| − | [[Image:Advanced Tissue Sciences.jpg|right|thumb|]] | + | <!-- [[Image:Advanced Tissue Sciences.jpg|right|thumb|]] --> |
| − | Advanced Tissue Sciences is a corporation based in La Jolla, CA. They are the makers of [[Dermagraft-TC]], which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFwebQuote | + | '''Advanced Tissue Sciences''' is a corporation based in La Jolla, CA. They are the makers of [[Dermagraft-TC]], which is an artifical skin created from harvested foreskins from infant circumcision.<ref name='Advanced Biohealing, 2010'>{{REFwebQuote |
| quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | | quote=Dermagraft is manufactured from human fibroblast cells derived from newborn foreskin tissue. | ||
| last= | | last= | ||
Revision as of 15:20, 16 August 2019
Advanced Tissue Sciences is a corporation based in La Jolla, CA. They are the makers of Dermagraft-TC, which is an artifical skin created from harvested foreskins from infant circumcision.[1] They are also the makers of NouriCel, another product made from harvested foreskins,[2] and one of the main ingredients of SkinMedica's TNS Recovery Complex product.[3]
Earnings
Dermagraft-TC is FDA approved,[4][5] and it sells for about $3,000 per square foot and one foreskin contains enough genetic material to grow 250,000 square feet of skin.[6]
Advanced Tissue Sciences has sold about $1 million worth of cultured dermis to Proctor & Gamble, Helene Curtis, and other such businesses for pre-market testing. Advanced Tissue Science's foreskin-derived merchandise held a $32 million stock offering in the beginning of 1992.[7]
In 1996 alone, Advanced Tissue Sciences could boast of a healthy $663.9 million market capitalization performance.[8]
References
- ↑ Template:REFwebQuote
- ↑ Template:REFwebQuote
- ↑ Template:REFwebQuote
- ↑ Template:REFwebQuote
- ↑ Template:REFwebQuote
- ↑ Circumcision. Daecher M. Icon 1998;2(2):70-3.
- ↑
Pitta, Julie (10 May 1993): Biosynthetics. Forbes. Pp. 170-171.
Note: The 32-page Advanced Tissue Sciences, Inc. 1997 Annual Report refers to "fibroblasts" but does not contain the word "foreskin." - ↑ Biotech's Big Discovery. Hall CT. San Francisco Chronicle. October 25, 1996: E1, E4.
